Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

(2011) Jennifer Franke et al.   Clinical Research in Cardiology

Biomarkers: optimizing treatment guidance in heart failure

(2011) Michael Böhm et al.   Clinical Research in Cardiology

Galectin-3 in heart failure: high levels are associated with all-cause mortality

(2011) Thor Ueland et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases

(2011) Allegra Battistoni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

(2010) Rudolf A. de Boer et al.   ANNALS OF MEDICINE

Multi-center determination of galectin-3 assay performance characteristics:

(2010) Robert H. Christenson et al.   CLINICAL BIOCHEMISTRY

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

(2010) Dirk J. A. Lok et al.   Clinical Research in Cardiology

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

(2010) Ravi V. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure — A meta-analysis

(2010) Andrew Binder et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study

(2009) G. L. Nicolosi et al.   EUROPEAN HEART JOURNAL

Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis

(2009) R. J. van Bommel et al.   EUROPEAN HEART JOURNAL

Old and new biomarkers of heart failure

(2009) Michele Emdin et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical and Prognostic Value of Galectin-3, a Novel Fibrosis-Associated biomarker, in Patients with Chronic Heart Failure

(2009) Dirk J. van Veldhuisen et al.   JOURNAL OF CARDIAC FAILURE

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

(2008) et al.   EUROPEAN HEART JOURNAL

Plasma Biomarkers of Myocardial Fibrosis and Remodeling in Terminal Heart Failure Patients Supported by Mechanical Circulatory Support Devices

(2008) Hendrik Milting et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION